2-Dec-2024 5:06 AM CST - Zacks Should You Continue to Retain Bio-Techne Stock in Your Portfolio? Bio-Techne TECH is making notable strides in its four growth verticals, which are poised to help it grow in the upcoming quarters. The company is now pursuing clinical diagnostic opportunities on the Ella platform after achieving the ISO 13485 certification.
27-Nov-2024 6:38 AM CST - Yahoo Finance BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Healthcare Conference on Wednesday, December 4, 2024,
21-Nov-2024 11:28 AM CST - Barchart Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. With a market cap of $10.9 billion,
20-Nov-2024 9:56 AM CST - Business Insider Bio-Techne announces partnership with Leader Life Sciences Bio-Techne (TECH) announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of
31-Oct-2024 10:10 AM CST - Business Insider Bio-Techne Reports First Quarter Fiscal 2025 Results Bio-Techne ( (TECH) ) has realeased its Q1 earnings. Here is a breakdown of the information Bio-Techne presented to its investors. Bio-Techne
30-Oct-2024 11:02 AM CST - Zacks Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket Bio-Techne TECH reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The company also exceeded the year-ago period figure by a penny.
2-Dec-2024 5:06 AM CST - Zacks Should You Continue to Retain Bio-Techne Stock in Your Portfolio? Bio-Techne TECH is making notable strides in its four growth verticals, which are poised to help it grow in the upcoming quarters. The company is now pursuing clinical diagnostic opportunities on the Ella platform after achieving the ISO 13485 certification.
27-Nov-2024 6:38 AM CST - Yahoo Finance BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Healthcare Conference on Wednesday, December 4, 2024,
21-Nov-2024 11:28 AM CST - Barchart Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. With a market cap of $10.9 billion,
20-Nov-2024 9:56 AM CST - Business Insider Bio-Techne announces partnership with Leader Life Sciences Bio-Techne (TECH) announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of
31-Oct-2024 10:10 AM CST - Business Insider Bio-Techne Reports First Quarter Fiscal 2025 Results Bio-Techne ( (TECH) ) has realeased its Q1 earnings. Here is a breakdown of the information Bio-Techne presented to its investors. Bio-Techne
30-Oct-2024 11:02 AM CST - Zacks Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket Bio-Techne TECH reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The company also exceeded the year-ago period figure by a penny.
